Equipment replacement to maintain sequencing capability at a Canadian university
Official title: Equipment replacement - Purchase of MiSeq i100 to replace MiSeq
Funded at University of Guelph · NIH-11523925 · Data updated 2026-11-12
A university project is replacing an old MiSeq instrument to keep sequencing capabilities up to date for research that could involve patients indirectly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Guelph NIH-funded |
| Lab location | 1 site (Guelph, Canada) |
| Project start | September 1, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $60,000 |
| NIH project number | 1U18FD008918-01 |
| Project ID | NIH-11523925 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable; this is an equipment upgrade at a university lab.
✕Less likely to help
There is no direct patient contact or enrollment in this grant.
What this research studies
This grant funds upgrading sequencing equipment to ensure the lab can continue generating genetic data when needed. The project focuses on maintaining a high-quality platform for studies that may eventually relate to human health, with routine maintenance and a newer model providing more reliable data. The plan involves procurement and installation of the MiSeq i100, ensuring continued access for researchers who work with human-related samples or translational projects. The description here emphasizes infrastructure continuity rather than a direct patient trial.
Why it matters
Potential benefit: Keeping cutting-edge sequencing capabilities available can accelerate future studies that may lead to patient-relevant discoveries.
How similar studies have gone: Equipment upgrades of sequencing platforms have historically supported successful downstream human research.
Where this research is happening
-
University of Guelph
Guelph, Canada Active
Researchers
- Principal investigator: Slavic, Durda — University of Guelph
- Study coordinator: Slavic, Durda
Related research
Other NIH-funded projects on the same topics.
-
Understanding how CMV keeps quiet or wakes up inside our cells
This grant studies how human cytomegalovirus (HCMV) hides in cells and what signals can make it reactivate, with the goal of helping people at risk of CMV-related illness.
-
Antimicrobial resistance surveillance using whole genome sequencing of animal bacteria in Canada
A Canadian university lab will collect bacterial isolates from animals, test their resistance to antibiotics, and analyze their genomes to help track AMR trends.
-
Tracking antibiotic resistance in animals across Canada
This study is looking at how germs that resist antibiotics are spreading in animals across Canada, and it's working to make our food safer for everyone by teaming up with veterinary labs to track and understand these germs better.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.